gebhart/patrepeval huggingface dataset:
A Study on the ebXML Business Transation Models Exploiting XML Security Technologies (2008)

ebXML (Electronic Business using eXtensible Markup Language) is an e-business standard, sponsored by UN/CEFACT and OASIS, which enables enterprises to exchange business messages, conduct trading relationships, communicate data in common terms and define and register business processes. While there is tremendous e-business value in the ebXML, security remains an unsolved problem and one of the largest barriers to adoption.XML security technologies emerging recently have extensibility and flexibility suitable for security implementation such as encryption, digital signature, access control and authentication. In this paper, we propose ebXML business transaction models that allow trading partners to securely exchange XML based business transactions by employing XML security technologies. We show how each XML security technology meets the ebXML standard by constructing the test software and validating messages between the trading partners.
Erythropoietin secretion by isolated rat Kupffer cells. (1984)

Hepatic parenchymal and Kupffer cells were isolated from regenerating rat liver and maintained in primary culture in an attempt to identify the cell type responsible for extrarenal erythropoietin (Ep) production. Conditioned media from Kupffer cell cultures were shown to contain Ep. Kupffer cells were cultured in the presence and absence of serum, but only cultures with serum contained bioactive Ep. The addition of latex beads to Kupffer cell cultures increased the amount of Ep secreted. Parenchymal-cell-conditioned media were negative for Ep activity. Isolated liver macrophages might be useful in vitro for the study of Ep elaboration.
Silicon as a mechanical material (1982)

Single-crystal silicon is being increasingly employed in a variety of new commercial products not because of its well-established electronic properties, but rather because of its excellent mechanical properties. In addition, recent trends in the engineering literature indicate a growing interest in the use of silicon as a mechanical material with the ultimate goal of developing a broad range of inexpensive, batch-fabricated, high-performance sensors and transducers which are easily interfaced with the rapidly proliferating microprocessor. This review describes the advantages of employing silicon as a mechanical material, the relevant mechanical characteristics of silicon, and the processing techniques which are specific to micromechanical structures. Finally, the potentials of this new technology are illustrated by numerous detailed examples from the literature. It is clear that silicon will continue to be aggressively exploited in a wide variety of mechanical applications complementary to its traditional role as an electronic material. Furthermore, these multidisciplinary uses of silicon will significantly alter the way we think about all types of miniature mechanical devices and components.
Identifying continuing educational needs among oncologists in managing patients with pancreatic cancer. (2018)

e16233 Background: Most patients with pancreatic ductal adenocarcinoma (PDAC) are diagnosed with advanced disease and are ineligible for potentially curative surgical resection. Oncologists are faced with considering all treatment options, including experimental agents in clinical trials. The goal of this study was to identify the current practice of US-practicing medical oncologists in the management of patients with advanced PDAC in order to ascertain future continuing medical educational (CME) needs. Methods: Oncologist practice was assessed using a case-vignette survey with multiple-choice and Likert-type questions designed to elicit clinical management decisions, determine familiarity with new and emerging therapy, and assess challenges to managing patients with PDAC. The survey featured two vignettes: 1) a 55 year-old male with a pancreatic tail mass and numerous liver metastases 2) a 77 year-old male with a pancreatic head mass, biliary obstruction, and metastases to the liver and peritoneal cavity. Results: Responses were collected from 150 medical oncologists using a quota method; 69% practiced in a community setting and 31% were academicians. Results demonstrated a lack of consensus in management selections, notably when sequencing therapy. Further, few ( < 10%) recommended a clinical trial in either vignette. Academic oncologists reported a higher percentage of patients with stage IV PDAC enrolled in clinical trials compared to community oncologists (30% vs 14%, P < .001). However, 36% of all oncologists rated ‘lack of access to clinical trials’ as a significant barrier to patient care. Variation was also noted in familiarity with pathophysiology and knowledge of therapies to treat PDAC, with academic oncologists reporting significantly higher familiarity compared to community oncologists. Conclusions: By assessing the practice patterns of oncologists managing patients with advanced PDAC, this study identified variation in management decisions and demonstrated continuing educational needs. Future CME that is centered on identified educational needs will help oncologists continue to translate the latest evidence into practice and provide optimal care of patients with PDAC.
An Electrochemical Study of the Oxidation of Hydrogen at Platinum Electrodes in Several Room Temperature Ionic Liquids (2007)

The electrochemical oxidation of dissolved hydrogen gas has been studied in a range of room-temperature ionic liquids (RTILs), namely [C(2)mim][NTf(2)], [C(4)mim][NTf(2)], [N(6,2,2,2)][NTf(2)], [P(14,6,6,6)][NTf(2)], [C(4)mpyrr][NTf(2)], [C(4)mim][BF(4)], [C(4)mim][PF(6)], [C(4)mim][OTf], and [C(6)mim]Cl on a platinum microdisk electrode of diameter 10 microm. In all cases, except [C(6)mim]Cl, a broad quasi-electrochemically reversible oxidation peak between 0.3 to 1.3 V vs Ag was seen prior to electrode activation ([C(6)mim]Cl showed an almost irreversible wave). When the electrode was pre-anodized ("activated") at 2.0 V vs Ag for 1 min, the peak separations became smaller, and the peak shape became more electrochemically reversible. It is thought that the electrogenerated protons chemically combine with the anions (A-) of the RTIL. The appearance and position of the reverse (reduction) peak on the voltammograms is thought to depend on three factors: (1) the stability of the protonated anion, HA, (2) the position of equilibrium of the protonation reaction HA<==> H+ + A- , and (3) any follow-up chemistry, e.g., dissociation or reaction of the protonated anion, HA. This is discussed for the five different anions studied. The reduction of HNTf(2) was also studied in two [NTf(2)]- -based RTILs and was compared to the oxidation waves from hydrogen. The results have implications for the defining of pKa in RTIL media, for the development of suitable reference electrodes for use in RTILs, and in the possible amperometric sensing of H2 gas.
APC promoter hypermethylation is an early event in endometrial tumorigenesis (2009)

The aim of the current study was to investigate the role of promoter methylation of adenomatous polyposis coli (APC) and epithelial cadherin (E-cadherin) genes in endometrial tumorigenesis. The methylation status of both genes was investigated in 43 cases of normal endometrium, 21 simple hyperplasia, 17 atypical hyperplasia, and 86 endometrial carcinoma (EC). Additionally, the methylation pattern of both genes was analyzed in 24 primary ECs and their corresponding metastases. DNA methylation of the APC gene increased from atypical hyperplasia (23.5%) to endometrial carcinoma, reaching its highest level of 77.4% in early stage cancer (FIGO I and II) and decreasing stepwise to 24.2% in advanced stage carcinomas (FIGO III and IV). No methylation of APC was found in normal endometrium or simple hyperplasia. Methylation of E-cadherin was found only in EC (22.1%). The mean age of the patients with aberrant APC methylation was 68.8 years and was significantly higher compared to the mean age (60.9 years) of the patients without methylation of APC promoter (P = 0.02). APC promoter methylation significantly correlated with decreased protein expression of APC (P = 0.039), with increased expression of the Ki-67 proliferative marker (P = 0.006) and decreased metastatic potential (P = 0.002). There was no correlation between APC and E-cadherin methylation patterns and the other clinicopathologic features, nor with patient outcome. Our results suggest that hypermethylation of APC promoter region is an early event in endometrial tumorigenesis.
Identifying the pairing symmetry in the Sr2RuO4 superconductor (2000)

We have analyzed heat capacity and thermal conductivity measurements of Sr2RuO4 in the normal and superconducting state and come to the conclusion that an order parameter with nodal lines on the Fermi surface is required to account for the observed low-temperature behavior. A gapped order parameter is inconsistent with the reported thermodynamic and transport data. Guided by a strongly peaked dynamical susceptibility along the diagonals of the Brillouin zone in neutron scattering data, we suggest a spin-fluctuation mechanism that would favor the pairing state with the gap maxima along the zone diagonals (such as for a d_{xy} gap). The most plausible candidates are an odd parity, spin-triplet, f-wave pairing state, or an even parity, spin-singlet, d-wave state. Based on our analysis of possible pairing functions we propose measurements of the ultrasound attenuation and thermal conductivity in the magnetic field to further constrain the list of possible pairing states.
Down-regulation of B Cell Receptor Signaling by Hematopoietic Progenitor Kinase 1 (HPK1)-mediated Phosphorylation and Ubiquitination of Activated B Cell Linker Protein (BLNK) (2012)

Hematopoietic progenitor kinase 1 (HPK1) is a Ste20-like serine/threonine kinase that suppresses immune responses and autoimmunity. B cell receptor (BCR) signaling activates HPK1 by inducing BLNK/HPK1 interaction. Whether HPK1 can reciprocally regulate BLNK during BCR signaling is unknown. Here, we show that HPK1-deficient B cells display hyper-proliferation and hyper-activation of IκB kinase and MAPKs (ERK, p38, and JNK) upon the ligation of BCR. HPK1 attenuates BCR-induced cell activation via inducing BLNK threonine 152 phosphorylation, which mediates BLNK/14-3-3 binding. Furthermore, threonine 152-phosphorylated BLNK is ubiquitinated at lysine residues 37, 38, and 42, leading to attenuation of MAPK and IκB kinase activation in B cells during BCR signaling. These results reveal a novel negative feedback regulation of BCR signaling by HPK1-mediated phosphorylation, ubiquitination, and subsequent degradation of the activated BLNK.
Determination of elastic constants of a concrete specimen using transient elastic waves (1995)

This paper presents the results of measuring the Rayleigh wave as well as longitudinal wave velocities in a concrete specimen using transient elastic waves. The Rayleigh surface wave generated by a steel ball impact on a concrete material is studied in detail and then a method for the determination of Rayleigh surface wave velocity based on the cross-correlation method is proposed. The longitudinal wave velocity of a concrete specimen is determined by measuring the wavefront arrival of a longitudinal wave. A special triggering device for the accurate determination of the impact time origin is utilized. The measured velocities of both the Rayleigh wave and the longitudinal wave in the concrete specimen are in good agreement with those measured by utilizing the conventional ultrasonic method. It is noted that with the Rayleigh wave and the longitudinal wave velocities measured, the Young’s modulus as well as the shear modulus of a concrete specimen can be obtained in a straightforward way.
Properties of a tunneling injection quantum-well laser: Recipe for 'cold' device with a large modulation bandwidth (1993)

A quantum-well laser in which electrons are directly injected into the lasing quantum well by resonant tunneling is proposed and demonstrated. The preliminary GaAs-based devices, grown by molecular beam epitaxy have an 80-AA In/sub 0.1/Ga/sub 0.9/As active single quantum well and AlAs tunneling barriers. I/sub th/ is 15 mA in a single-mode ridge device and the differential gain is approximately 2*10/sup -16/ cm/sup -2/. The principle of operation promises a 'cold' laser at high injection levels, and therefore Auger recombination and chirp are expected to be suppressed. In addition, tunneling of carriers into the active well as the potential to achieve large modulation bandwidths.< <ETX xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&gt;</ETX>
A 900 MHz, 2.5 mA CMOS frequency synthesizer with an automatic SC tuning loop (2002)

A 900 MHz PLL frequency synthesizer implemented in 0.6 /spl mu/m CMOS technology is developed for WINS (Wireless Integrated Network Sensors) applications. It incorporates an automatic SC discrete-tuning loop to extend the frequency tuning range to 20% while the VCO gain from the CMOS varactor continuous-tuning is kept low at only 20 MHz/V, to minimize the reference spurs. This frequency synthesizer achieves a phase noise of -102 dBc/Hz at 100 kHz offset and reference spurs below -55 dBc. The synthesizer, including an on-chip VCO, dissipates only 2.5 mA from a 3 V supply.
Abstract 565: A novel T-cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors (2019)

Abstract Agonistic monoclonal antibodies targeting CD137/4-1BB have shown much preclinical promise but their clinical development has been slowed due to a poor therapeutic index, in particular liver toxicity. CB307 is a novel half-life extended bispecific Humabody VH targeting CD137 (4-1BB) and prostate specific membrane antigen (PSMA). The design of CB307 enables agonism of CD137 selectively in the presence of PSMA positive tumour cells and in this way enable tumour selective T cell activation whilst minimising systemic activation. The molecular weight of CB307 is less than 50 kDa (around a third of the size of a standard IgG) and it does not contain an Fc domain, thereby avoiding interaction with Fc receptors. Half life extension is achieved through the inclusion of a VH domain with specificity for human serum albumin (HSA). The identification of CB307 using the Crescendo Mouse™ which develops fully human VH domains in a background devoid of light chains will be described along with characterisation of the key properties of the molecule in in vitro and in vivo models. In dual target binding assays CB307 shows potent co-binding to both PSMA and CD137 targets and mediates CD137 signalling in an NFKB cell reporter assay in the presence of PSMA positive cells but not PSMA negative cells. Co-incubation of primary human T-cells from healthy individuals or cancer patients together with PSMA positive tumour cells and CD3 stimulation induces T-cell activation and cytokine release. In an in vivo model using NSG mice engrafted with human PBMCs the growth of PSMA positive DU145 prostate tumour cells is inhibited by a surrogate bispecific. Together these data support progression of CB307 into clinical development. Citation Format: James W. Legg, Brian McGuinness, Sophie Archer, Phil Bland-Ward, Verena Brucklacher, Jenny Craigen, Carolyn Edwards, Emma Hames, Jay Majithiya, pavel Pisa, Bhindu Revi, Nikki Royale, Angelica Sette, Yumin Teng, Lorraine Thompson, Wembin Wang, Chris Wilson, Chris Wyre, Chris Rossant. A novel T-cell costimulatory Humabody® VH therapeutic for PSMA-positive tumors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 565.
Identification of autoantibodies specific for the neutrophil adhesion glycoproteins CD11b/CD18 in patients with autoimmune neutropenia (1991)

Anti-neutrophil antibodies have been described in a variety of clinical conditions associated with neutropenia. However, relatively little is known about the antigenic specificities of naturally occurring anti-neutrophil autoantibodies. We investigated the possibility that anti-neutrophil antibodies specific for the neutrophil adhesion glycoprotein (GP) complex CD11b/CD18 might be present in the sera of some patients with autoimmune neutropenia. These membrane GPs have been shown to be highly immunogenic in the production of murine monoclonal antibodies against neutrophil antigens. Moreover, autoantibodies to the platelet membrane GP complex IIb/IIIa, another member of the integrin family of cell adhesion proteins, have been demonstrated in immune thrombocytopenic purpura. Sera from 50 patients known to have anti-neutrophil IgG antibodies were evaluated using an immunobead "antigen capture" assay, modeled after a method used to identify anti-platelet GPIIb/IIIa autoantibodies. This assay detected anti-CD11b/CD18 autoantibodies in seven of the 50 sera. Each of these seven sera demonstrated decreased IgG binding to the neutrophils of a patient with congenital deficiency of CD11b/CD18. The patient with the highest levels of anti-CD11b/CD18 suffered recurrent skin infections and cellulitis, and died of respiratory failure during one of multiple episodes of pneumonia. Purified IgGs from five of these patients demonstrated effects on adhesion and/or opsonin receptor-mediated functions when tested with intact neutrophils in vitro. Our findings indicate that some patients with autoimmune neutropenia have autoantibodies specific for the functionally important neutrophil adhesion proteins CD11b/CD18. Our findings also raise the possibility that these autoantibodies may, in some cases, interfere with neutrophil function, thereby amplifying the risk of infection associated with neutropenia.
Laminin interacts with plasminogen and its tissue‐type activator (1984)

Laminin Plasminogen Plasminogen activator Proteolysis
Low-power consumption silica-based 2 x 2 thermooptic switch using trenched silicon substrate (1999)

We propose a silica-based 2/spl times/2 thermooptic switch using heat insulating grooves and trenches on a Si substrate to reduce electric power consumption. The switching power of a fabricated switch was successfully reduced to 135 mW, less than 1/3 that of a conventional switch. No detrimental effect on optical characteristics was observed: we obtained the insertion loss of 1 dB, the extinction ratio of better than 30 dB and no polarization dependency.
The Metabolic Syndrome as Predictor of Type 2 Diabetes (2003)

The metabolic syndrome predicts diabetes independently of other factors. However, the NCEP definition performs better than the modified 1999 WHO definition. Lowering the fasting glucose cutoff to 5.4 mmol/l improves the prediction of diabetes by the metabolic syndrome.
The Evolutionary Pressure to Inactivate (1997)

Synaptotagmin I is a Ca2+-binding protein of synaptic vesicles that serves as a Ca2+ sensor for neurotransmitter release and was the first member found of a large family of trafficking proteins. We have now identified a novel synaptotagmin, synaptotagmin XI, that is highly expressed in brain and at lower levels in other tissues. Like other synaptotagmins, synaptotagmin XI has a single transmembrane region and two cytoplasmic C2-domains but is most closely related to synaptotagmin IV with which it forms a new subclass of synaptotagmins. The first C2-domain of synaptotagmin I (the C2A-domain) binds phospholipids as a function of Ca2+ and contains a Ca2+-binding site, the C2-motif, that binds at least two Ca2+ ions via five aspartate residues and is conserved in most C2-domains (Shao, X., Davletov, B., Sutton, B., Südhof, T. C., Rizo, J. R. (1996) Science 273, 248-253). In the C2A-domains of synaptotagmins IV and XI, however, one of the five Ca2+-binding aspartates in the C2-motif is substituted for a serine, suggesting that these C2-domains do not bind Ca2+. To test this, we produced recombinant C2A-domains from synaptotagmins IV and XI with either wild type serine or mutant aspartate in the C2-motif. Circular dichroism showed that Ca2+ stabilizes both mutant but not wild type C2-domains against temperature-induced denaturation, indicating that the mutations restore Ca2+-binding to the wild type C2-domains. Furthermore, wild type C2A-domains of synaptotagmins IV and XI exhibited no Ca2+-dependent phospholipid binding, whereas mutant C2A-domains bound phospholipids as a function of Ca2+ similarly to wild type synaptotagmin I. These experiments suggest that a class of synaptotagmins was selected during evolution in which the Ca2+-binding site of the C2A-domain was inactivated by a single point mutation. Thus, synaptotagmins must have Ca2+-independent functions as well as Ca2+-dependent functions that are selectively maintained in distinct members of this gene family.
SCALE INVARIANCE IN SELECTIN-MEDIATED LEUKOCYTE ROLLING (2004)

White blood cells slowly roll along the walls of blood vessels, due to the coordinated formation and breakage of chemical selectin-carbohydrate bonds. Using detailed computer simulations of cells rolling on a selectin surface under flow, we show the time series of the cell translational velocity to be fractal in nature over time scales ranging from 2 2 –2 11 ms. A rescaled range analysis was performed to determine the Hurst exponent of the velocity time series, for simulations of cells rolling on either a uniform or punctate distribution of P-selectin molecules. The rolling behavior was found to exhibit two very distinct regimes, with a negative Hurst exponent ranging from -(1.2-0.6) over time scales of 2 3 -2 7 ms, and a positive Hurst exponent of +0.47±0.03 over time scales of 2 7 -2 11 ms. The short-time Hurst exponent was found to be a strong function of the molecular distribution and also a function of average molecular density, while the long-time Hurst exponent was unchanged over all conditions studied. The implication is that the short-time adhesive behavior of cells interacting with a reactive surface is sensitive to the spatial arrangement of molecules, and the total number of molecules on the surface.
Regional location of T cell receptor gene Ti alpha on human chromosome 14. (1985)

The chromosomal location of Ti alpha was determined by hybridization of a radiolabeled cDNA for the alpha chain of human T cell receptor with 12 human X mouse cell hybrid DNAs cleaved with BamHI. Seven hybrids contained human Ti alpha, while the remaining five lacked it. Only human chromosome 14 matched the distribution of human Ti alpha signal across the mapping panel. Hybrids segregating a chromosome 14 translocation were used to demonstrate that Ti alpha is in the region 14pter greater than 14q21. Thus, the alpha and beta chain genes that contribute structural components to the Ti moiety of the human T cell receptor lie on different chromosomes. In humans, the immunoglobulin heavy chain locus and Ti alpha are in different regions of chromosome 14, with Ti alpha more proximal and the immunoglobulin heavy chain locus more distal.